Selcia joins Eurofins Group

26-Jan-2018 - Selcia Limited announces that it has been acquired by Eurofins Scientific, a global leader in analytical testing and pharma discovery services. The acquisition of Selcia provides Eurofins with an entry into the custom radiolabelling and innovative pre-clinical, integrated drug discovery services ...

New drugs to target sleeping sickness

University of Edinburgh and Selcia achieve key milestones

01-Dec-2015 - Scientists from the University of Edinburgh, working with Selcia have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2.5 million project to design novel treatments for sleeping sickness. The aim of the project is to design a drug to inhibit a key parasite ...

Selcia and NeuroVive to Develop New Mitochondrial Medicines for Chronic and Acute Diseases

20-Sep-2011 - Selcia Limited and NeuroVive Pharmaceutical AB have signed a significant research collaboration agreement to develop new medicines and drug compounds targeting mitochondrial physiology and pathophysiology. The collaboration is focused on mitochondrial medicine, an emerging therapeutic modality ...

Selcia Appoints Simon Saxby as CEO and Andreas Rummelt to its Board

24-Feb-2011 - Selcia appointed Simon Saxby as its Chief Executive Officer (CEO). He will assume his position in April and takes over from Dr Hans Fliri who retains his role as Chairman of the Board. Selcia also announce the appointment of Dr Andreas Rummelt as a Non-Executive Director.Simon Saxby was until ...

Selcia awarded GMP certificate for preparation and carbon-14 labelling of APIs for clinical trials

09-Dec-2010 - Selcia Limited announced that its radiochemistry facility has been granted a Good Manufacturing Practice (GMP) certificate for the preparation and C-14 labelling of Active Pharmaceutical Ingredients (APIs) for clinical trials following a successful inspection by the UK’s Medicines and Healthcare ...

Selcia and Gilead Sciences Extend Liver Disease Drug Discovery Collaboration

01-Dec-2010 - Selcia Limited announced a drug discovery collaboration agreement with Gilead Sciences, Inc.. Building on an established partnership following significant progress made to date, Selcia’s chemists and biologists will continue to provide integrated drug discovery services to support Gilead’s liver ...

Convergence Pharmaceuticals and Selcia Announce Drug Discovery Collaboration Around Chronic Pain

23-Nov-2010 - Convergence Pharmaceuticals Limited and Selcia Limited announced that they have entered into a drug discovery collaboration to identify and develop high quality candidate molecules for the treatment of chronic pain. Under the terms of the agreement, Convergence Pharmaceuticals will apply its ion ...